The NHS has signed the first-of-its-kind subscription deal for two antimicrobial drugs - cefiderocol and ceftazidime-avibactam, manufactured by Shionogi and Pfizer respectively - that will help around 1700 patients per year with severe bacterial infections.
Under this deal, pharmaceutical firms will receive a fixed yearly fee - capped at a level that represents value to taxpayers - in order to incentivise funding for innovation that can generate a pipeline of new antibiotics for NHS patients.
NHS said the deal will help patients with serious infections that have evolved so much that antibiotics and other current treatments are no longer effective can be
given a potentially life-saving alternative. The drugs will provide a lifeline to patients with life-threatening infections like sepsis, hospital or ventilator pneumonia and blood stream infection.
Announcing the deal at NHS ConfedExpo, NHS Chief Executive Amanda Pritchard called the revolutionary subscription deal a game-changer and the latest NHS success in using its commercial power to benefit NHS patients in line with the NHS Long Term Plan.
"Superbug-busting drugs on the NHS will save lives and strike a blow in the global battle against antimicrobial resistance," Pritchard said.
The government has earmarked £200 million to enhance NHS resilience and expedite patient care during the upcoming winter season. This extra amount will
bolster the health service during its busiest period, while protecting elective care so we can keep cutting waiting lists, Prime Minister Rishi Sunak has said.
On August 13, the Prime Minister and Health and Social Care Secretary met with clinical leaders and NHS Chiefs to strategise and refine planning for urgent and
emergency care, while prioritising the preservation of waiting list targets for the upcoming winter season.
"Patients can be reassured that I will always back the NHS, so that those who most need help and support will get the care they need," Sunak said. "Winter is
the most challenging time for the health service, which is why we've been planning for it all year - with huge government investment to fund new ambulances, beds
and virtual wards."
"This £200 million investment, assured by the Department of Health and Social Care as new and additional funding, should aid NHS leaders in their preparations and
mitigation for what will be a seriously difficult winter period," said Matthew Taylor, Chief Executive of NHS Confederation. "The priority now is swift allocation
of funding to local systems for optimal utilisation."
In its response to NHS England's consultation on 'the future of vaccination services', the Pharmaceutical Services Negotiating Committee (PSNC) has suggested
that a wider range of NHS vaccinations being available from community pharmacies could support the achievement of increased vaccination levels.
PSNC said: "Any additional services that contractors could provide can only be considered with additional remuneration above the current global sum in the community
pharmacy contractual framework to ensure that the services are adequately resourced."
Alastair Buxton, director of NHS Services at PSNC, said: "We've always known, and the evidence supports this, that community pharmacies are one of the most popular
and accessible places for people to receive a range of vaccinations.
"The NHS was slow to take advantage of this at the start of the Covid-19 pandemic, so we welcome this consultation from them to bring together a wide range of views
on the topic.
"In the longer-term, if the right funding and support is in place, many pharmacies could help deliver a much wider range of NHS vaccination programmes - giving the
public the convenience and service that they want, and taking pressure off our general practice colleagues. It makes perfect sense, and we look forward to the NHS
response to this consultation."
The UK government on Wednesday (7 February) announced a new plan to ensure faster, simpler and fairer access to NHS dental care across England.
Supported by £200m of funding, the plan aims to deliver more than 1.5 million additional NHS dentistry treatments or up to 2.5 million NHS dental appointments
for patients over the next 12 months
NHS dentists will be offered a 'new patient' payment of between £15-£50, depending on treatment need, to treat new patients who have not seen a dentist in two
years or more.
Additionally, one-off payments of up to £20,000 will be given to around 240 dentists for working in under-served areas for up to three years.
This is to "attract new NHS dentists and improve access to dental care in areas with the highest demand," NHS England said in a statement released on Wednesday.
The NHS claims that it's been able to save taxpayers £1.2 billion in just three years by procuring hundreds of hospital medicines at a better price.
The adoption of cheaper versions of a single drug - adalimumab - which is used to treat more than 45,000 patients with rheumatoid arthritis, inflammatory bowel
disease and psoriasis, has accounted for about one third of the savings.
After the exclusive patent on the drug - originally known as its brand name Humira - expired in 2018, the NHS struck cost-saving deals to bulk-buy generic versions,
which have the same quality, safety and efficacy of a branded one.
Since then, tens of millions of pounds have been saved by buying cheaper generic versions of other medicines for conditions ranging from severe skin infections to
aggressive blood cancers.
Four in five medicines prescribed in the NHS are now non-branded, helping the NHS to achieve significant savings while ensuring the continuity of high-quality
patient care.
NHS chief executive Amanda Pritchard said: "Smart deals by the NHS mean patients are getting the best medicines and taxpayers are getting best value.
Health leaders have said that delivering faster and more productive patient care would be difficult unless NHS capital budgets are nearly doubled to
at least £14.1 billion from the current spending of £7.7 billion.
The NHS Confederation has highlighted the impact that low levels of capital investment have had over the last decade in its report published today (29 November).
The report, 'Investing to save: The capital requirement for a more sustainable NHS in England', revealed that the UK has lagged behind other comparable countries
in terms of health capital investment for more than five decades, resulting in less productivity.
It revealed that the NHS now has the sixth lowest number of CT and MRI scanners per million people of the OECD countries.
A groundbreaking research project has revealed that the public is urging the government to prioritise primary and community care over hospitals.
The study also found a strong public willingness to pay higher taxes to enhance NHS services.
The Health Foundation and Ipsos UK conducted the research, combining nationwide polling with in-depth public deliberative workshops.
These workshops, held in King's Lynn, Leeds, and London, constitute one of the most comprehensive public consultations about the future of the NHS in England.
The study published on 16 May underscores the public's desire for a redistribution of NHS resources. If the NHS budget remains unchanged, 60 per cent of those
polled believe the government should focus on improving access to community-based services like general practice and dentistry.
In his first speech as Secretary of State for Health and Social Care, Wes Streeting MP acknowledged that the NHS is in crisis while outlining his mission to
save the health service.
Streeting described the current state of the NHS as "broken," noting its failure to meet the needs of both patients and dedicated healthcare professionals.
"When we said during the election campaign, that the NHS was going through the biggest crisis in its history, we meant it.
"When we said that patients are being failed on a daily basis, it wasn't political rhetoric, but the daily reality faced by millions," he said on Friday (5 July).
The new health secretary remarked that previous governments had been unwilling to admit these simple facts.
The Green Party has previewed its upcoming manifesto with a bold proposal for the National Health Service (NHS) and social care system, promising an
unprecedented level of investment to restore and enhance these critical services.
By 2030, the Greens aim to inject over £50 billion annually into health and social care, accompanied by an additional £20 billion capital investment to modernise
healthcare infrastructure.
Green Party Co-Leader Adrian Ramsay emphasised the urgency of these reforms, stating, "Our NHS is at breaking point following 14 years of underfunding."
"Patients are stuck in hospital corridors, people can't see their GP or NHS dentist when they need to, and staff are severely overstretched."
The manifesto highlights a comprehensive approach to revitalising the NHS, including:
In a bid to revolutionise healthcare in the UK, the Reform Party has announced ambitious plans to offer tax incentives to pharmacies.
This move comes despite record extra funding in recent years, which has failed to halt a decline in NHS healthcare outcomes.
The party argues that while healthcare remains free at the point of delivery, significant reforms are essential to enhance results and eliminate waiting lists.
Central to the Reform Party's strategy is a set of critical reforms aimed at addressing NHS challenges within the first 100 days.
The implementation of tax breaks for pharmacies is intended to enhance accessibility and alleviate pressure on NHS resources.
A policy brief, developed by researchers from the University of Bath and University of Strathclyde with funding from Sigma Pharmaceuticals, has recommended
the Department of Health and Social Care (DHSC) and NHS to increase community pharmacy funding to avoid damaging closures and diminution of quality.
The report launched on Wednesday (12 June) at an event in the House of Commons, attended by Members of Parliament, senior policymakers and the pharmacy industry,
analysed community pharmacy policies and spoke to stakeholders to explore their opinions of the future of community pharmacy.
It was found that patients value their community pharmacies, but staff feel demotivated, insecure and undervalued.
Stakeholders and policies suggested that in the future, medicines should be supplied by automated 'hub and spoke' dispensing, enabling community pharmacy staff to
provide services that relieve pressure on GP surgeries, such as long-term conditions management, urgent care and public health.
Trust leaders involved in the New Hospital Programme (NHP) have warned that further delays in the government scheme will lead to more patient harm,
disappointment among staff, and higher costs for taxpayers.
According to NHS Providers, delays in the government scheme that promised 40 new hospitals in England by 2030 are draining millions of pounds from scarce NHS
funds every month.
Some trusts are compelled to spend over £1 million a month from their under-pressure budgets due to spiraling cost pressures, on-hold building projects, and the
bill for having to patch up deteriorating sites.
While there has been some progress over the past year, trust leaders remain apprehensive that "uncertainty over funding and shifting timetables risks putting
their promised buildings further out of reach."
The government has allocated an additional 350 medical school places in England, making a significant step in delivering the NHS Long Term Workforce Plan.
Supported by more than £2.4 billion in government funding, the plan outlines the strategy for recruiting and retaining hundreds of thousands more staff over the
next 15 years to deliver the future workforce the NHS requires.
One of the key commitments of the NHS Long Term Workforce Plan is to double the number of medical school places in England to 15,000 by 2031.
As part of the ongoing efforts to fulfill this pledge, the Office for Students (OfS) has designated 350 places for medical schools nationwide for the academic year
2025 to 2026, targeting under-doctored areas.
Poverty not only takes a significant toll on people's health but also leads to additional costs for the National Health Service (NHS). Rise in deep poverty,
cost-of-living crisis, and high pressure on NHS services have worsened the situation, according to a study published by The King's Fund this week.
The report underscored that poverty and deprivation contribute to a greater prevalence of diseases, difficulties in accessing health care, late or delayed
treatment, and worse health outcomes. These challenges could be seen across various NHS services, spanning from emergency care to dental services
Additionally, it revealed that 30 per cent of people living in the most deprived areas have turned to 999, 111, A&E or a walk-in centre because they could not
access a GP appointment.
In 2016, the Joseph Rowntree Foundation (JRF) estimated the cost of poverty on health care at £29 billion (£34 billion in current prices). As the proportion of
people living in deep poverty has risen, the situation has worsened. In 2021/22, six million people were living in very deep poverty, up from 4.5 million two
decades ago. Currently, more than one in five people in the UK are estimated to be living in poverty, the report noted.
Deprivation is linked to a range of diet-related health problems, including cardiovascular disease and diabetes, as well as mental illness. According to the
report, the depression rate is two times higher among people living in the most deprived areas, compared to the least deprived areas.
The Health and Social Care Secretary has announced over £175 million funding to boost genomics research in the UK.
Through this funding, the government aims to create the most advanced genomic healthcare system in the world.
"Patients with cancer and children born with treatable rare genetic diseases are set to benefit from earlier diagnosis and faster access to treatment, following a
£175 million boost to cutting-edge genomics research announced by the Health and Social Care Secretary today (Tuesday)," said DHSC.
The funding will enable research which could deliver world-leading genomic healthcare to patients, which involves the study of people's DNA.
"£105 million to be funded to kickstart a world-leading research study, led by Genomics England in partnership with the NHS, to explore the effectiveness of using
whole genome sequencing to find and treat rare genetic diseases in newborn babies," said DHSC.
"An initial £26 million to support an innovative cancer programme, led by Genomics England in partnership with the NHS, to evaluate cutting-edge genomic sequencing
technology to improve the accuracy and speed of diagnosis for cancer patients and use artificial intelligence to analyse a person's DNA, alongside other information
such as routine scans.
Trade bodies have reiterated the call for more funding in response to the reports that ministers are considering a Pharmacy First scheme amid the NHS strike.
The Sunday Telegraph reported that pharmacies could be drafted in to help the NHS to cope when other healthcare workers take industrial action.
But, a PSNC committee member has warned on Monday that the government suggestions are "categorically impossible" without extra funding.
The Company Chemists' Association (CCA) has echoed the sentiment, saying pharmacy network is on the brink of collapse.
"We welcome plans for a Pharmacy First scheme in England. However, after eight years of funding cuts, the pressures on community pharmacies are simply untenable,"
Malcolm Harrison, chief executive of the CCA, said.
"Not improving our funding is not an option, if they want to continue to deliver anything like the level of patient care we have done in recent years," he
emphasised as he prepares for the NPA'S Save Our Pharmacies Day of Action (June 20).
Over the past two years, McElrea has navigated crises stemming from NHS Scotland policies, particularly concerning medicines price inflation and delayed payments.
"The cost of medicines increased rapidly compared to inflation," McElrea stated, noting NHS Scotland's slow response in adjusting tariff prices.
"This wiped out £50,000 of cash reserves and forced us into £30,000 of additional borrowings."
Delayed payments further strained operations, with McElrea highlighting the impact of payments based on outdated pricing.
As the countdown to the next UK election begins, the King's Fund has identified three priorities to improve public health.
The national action would be taken by the future government to fix the "NHS and social care" in the country.
The health policy think tank said it would prioritise "improving access to out-of-hospital care", making "careers in health and social care" more attractive
and tackling the biggest risk factors affecting people's health.
It highlighted that workforce crisis is one of the biggest challenges faced by the National Health Service (NHS) and social care services in England while
citing "years of poor planning and fragmented responsibilities" as the reason for widespread staff shortages.
As per the King's Fund's data, there were more than 125,000 vacancies across the NHS workforce in England in October 2023, not including primary care vacancies
such as GPs, and 152,000 vacant posts in the adult social care workforce.
In a decisive move highlighting the financial strain faced by community pharmacies, the National Pharmacy Association (NPA) submitted a £108 million invoice
to the Department of Health and Social Care (DHSC) today (16 May).
According to the NPA, this substantial sum represents the amount that pharmacies in England personally covered for the dispensing of NHS medicines last month, as a
result of inadequate funding.
"The £108m figure is an average monthly figure based on the loss to pharmacy incomes over the past decade," it said.
The association believes that mass closures can be prevented only when the government stops expecting pharmacies to subsidise the cost of delivering NHS care.
NPA chief executive Paul Rees, said: "The soaring costs of dispensing medicine coupled with declining real terms funding has led to community pharmacies in
England having to subsidise the dispensing of drugs to the tune of £108m a month.
Rising chronic illnesses and an aging population are threatening to bankrupt the National Health Service, Labour's Shadow Health Secretary Wes Streeting has
said on October 11.
Streeting announced a substantial £1.1 billion injection to strengthen the NHS with the goal of clearing the backlog and introducing additional clinics on
evenings and weekends.
The frontbencher outlined a reform agenda to ensure NHS is back on its head for the future of healthcare in the UK.
Streeting said that a Labour government will not waste "money we don't have"- instead aims to revolutionise the NHS by shifting its focus from hospitals to
communities.
"Our emphasis is on transitioning from an analogue to a digital framework and prioritising prevention over sickness-oriented healthcare," he noted.